Overview
Acute myeloid leukemia (AML) is a type of cancer that affects the bone marrow and white blood cells. It occurs when abnormal cells, called myeloblasts, grow quickly in the bone marrow and interfere with the production of healthy red and white blood cells, as well as platelets. AML is a serious illness that requires immediate treatment, and in some cases, can be fatal. Treatment options include chemotherapy, radiation therapy, stem cell transplantation and targeted therapy. The prognosis and outcome of AML vary depending on the patient's age, overall health, and the type and stage of the cancer.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 6 articles above have been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2022 · Hematology/Oncology and Stem Cell Therapy
-
2020 · Hematology/Oncology and Stem Cell Therapy
-
2019 · The Egyptian Journal of Hospital Medicine
-
Nawal M. Abdel Qawy et al. · 2019 · The Egyptian Journal of Hospital Medicine
-
2018 · Journal of Hematology and Oncology Research
-
2015 · International Journal Of Nutrition
-
2015 · International Journal Of Nutrition
A sample of recent works citing this journal's research on Acute Myeloid Leukemia, linking to each citing work.